In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection
Abstract Background Clostridium difficile infection is the leading cause of hospital-acquired gastrointestinal infection and incidence rates continue to rise. Clostridium difficile infection is becoming increasingly complex to treat owing to the rise in treatment failures and recurrent infections. T...
Saved in:
Main Authors: | Christine Roder (Author), Eugene Athan (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clostridium difficile infection
by: Stephen A. Geller, et al.
Published: (2014) -
Clostridium difficile
by: Emily Macnaughton
Published: (2014) -
Management of Primary and Recurrent Clostridium difficile Infection: An Update
by: Jocelyn Chai, et al.
Published: (2018) -
New advances in the treatment of Clostridium difficile infection (CDI)
by: Dennis D Hedge, et al.
Published: (2008) -
Antimicrobials for treating Clostridium difficile infections
by: K. Sridharan
Published: (2020)